Remove 2030 Remove Drug Development Remove Leadership
article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Centered on digital biomarker and safety monitoring algorithm development, with a specific emphasis on cytokine release syndrome (CRS) detection, the oncology programs harness cutting-edge data science and technology to elevate remote data collection, patient monitoring, and safety protocols. Full press release here

article thumbnail

Digital Health v HealthTech: What is the difference?

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. As we look towards 2030, several key trends are poised to reshape the industry: 1.

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. until 2032.